Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox in premature ejaculation
NCT06851598Phase 3Active, not recruiting
- Start
- Jul 2024
- Primary completion
- Feb 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in premature ejaculation (PE). Started Jul 2024; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT06851598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06851598.